Global lab scale ACM Global Laboratories is a large, multi-country central lab with over 20 million tests annually and capabilities across pathology, microbiology, molecular diagnostics, and toxicology, presenting broad opportunities for clinical trial support, toxicology workflows, and diagnostic services in potential new markets.

Clinical trial expansion Active involvement in infectious disease, vaccine studies, and therapeutic testing suggests readiness to partner on ongoing and upcoming clinical trials, including COVID-19 related programs and infectious disease therapeutics, offering scope for trial logistics, biomarker testing, and data management.

Acquisition heritage Recent integration of DrugScan and DSI Medical Services enhances toxicology, drug testing programs, and substance abuse testing capabilities, creating cross-sell opportunities for corporate clients needing comprehensive toxicology and drug monitoring across employee health and compliance programs.

Strategic tech stack Adoption of Sitecore, Snowflake, MasterControl and other enterprise tools indicates mature data management, regulatory compliance, and analytics infrastructure, which can be leveraged to sell integrated data reporting, quality management, and scalable lab information systems to partners.

Rochester linkage As an affiliate of Rochester Regional Health with CAP and SAMHSA certification, ACM presents credibility and access to a broad healthcare ecosystem, enabling partnerships with hospitals, biopharma, and government programs seeking trusted central laboratory services.